Answered: Six questions about cough syrup deaths linked to Haryana firm
- A deadly toxin found in syrup claimed lives of Indians too in the past. But manufacturers have rarely been punished.
BENGALURU : On 5 October 2022, the World Health Organisation (WHO) announced that four cough medicines, made by the Haryana-based manufacturer, Maiden Pharma, were suspected to have caused the deaths of 66 children in the West African nation, The Gambia. The brands—Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup—contained ingredients such as the anti-inflammatory drug paracetamol, and the anti-allergy drug chlorphenamine maleate.